395 related articles for article (PubMed ID: 12778885)
1. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
2. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
3. European best practice guidelines 17-18: adverse effects.
Hörl WH; Jacobs C; Macdougall IC; Valderrábano F; Parrondo I; Carveth BG; Thompson K
Nephrol Dial Transplant; 2000; 15 Suppl 4():51-6. PubMed ID: 11052149
[No Abstract] [Full Text] [Related]
4. Hemoglobin levels, quality of life, and survival.
Sadler JH; Meyer KB
Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
[No Abstract] [Full Text] [Related]
5. Influence of vascular access type on outcome measures in patients on maintenance hemodialysis.
Chand DH; Teo BW; Fatica RA; Brier M;
Nephron Clin Pract; 2008; 108(2):c91-8. PubMed ID: 18212514
[TBL] [Abstract][Full Text] [Related]
6. [Morbidity in hemodialysis].
Galindo P; Martínez Sánchez T; Osuna A; Asensio C
Nefrologia; 2002; 22(2):202-3. PubMed ID: 12085423
[No Abstract] [Full Text] [Related]
7. Managing the anemia of end-stage renal disease after hospitalization.
Krishnan M; Adams E
Nephrol Nurs J; 2004; 31(5):541-4. PubMed ID: 15518256
[TBL] [Abstract][Full Text] [Related]
8. Relationships between hemoglobin and hematocrit levels and hospitalization and survival rates in dialysis patients.
Brattich M
Nephrol Nurs J; 2003 Apr; 30(2):231-4. PubMed ID: 12737001
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
[No Abstract] [Full Text] [Related]
10. Target hemoglobin level for EPO therapy in CKD.
Parfrey PS
Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
[No Abstract] [Full Text] [Related]
11. Should the hematocrit be normalized in dialysis and in pre-ESRD patients?
Macdougall IC
Blood Purif; 2001; 19(2):157-67. PubMed ID: 11150803
[No Abstract] [Full Text] [Related]
12. [Stability of hemoglobin levels: an indispensible paradigm change in medical management].
Zaoui P; Deray G; Ortiz JP; Rostaing L
Nephrol Ther; 2011 Feb; 7(1 Suppl 2):H5-7. PubMed ID: 21371678
[No Abstract] [Full Text] [Related]
13. Association of quarterly average achieved hematocrit with mortality in dialysis patients: a time-dependent comorbidity-adjusted model.
Messana JM; Chuang CC; Turenne M; Wheeler J; Turner J; Sleeman K; Tedeschi P; Hirth R
Am J Kidney Dis; 2009 Mar; 53(3):503-12. PubMed ID: 19185402
[TBL] [Abstract][Full Text] [Related]
14. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
Cuero CJ; Pérez Guardia E; de Rivera C
Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
16. Managing anemia in dialysis patients: hemoglobin cycling and overshoot.
Singh AK; Milford E; Fishbane S; Keithi-Reddy SR
Kidney Int; 2008 Sep; 74(5):679-83. PubMed ID: 18337717
[No Abstract] [Full Text] [Related]
17. Vascular access for hemodialysis: the impact on morbidity and mortality.
Di Iorio BR; Bellizzi V; Cillo N; Cirillo M; Avella F; Andreucci VE; De Santo NG
J Nephrol; 2004; 17(1):19-25. PubMed ID: 15151255
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with high dose of intravenous iron increases mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Martín Reyes G; Valera A; Toledo R
Nefrologia; 2004; 24(1):87-8. PubMed ID: 15083966
[No Abstract] [Full Text] [Related]
19. Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients.
Volkova N; Arab L
Am J Kidney Dis; 2006 Jan; 47(1):24-36. PubMed ID: 16377382
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin.
Beresford CH
N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
